Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study
Emerging Classic

Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study.

Sud A, Torr B, Jones ME, et al. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study. Lancet Oncol. 2020 Jul 20. doi: 10.1016/S1470-2045(20)30392-2.

Save
Print
August 19, 2020
Sud A, Torr B, Jones ME, et al. Lancet Oncol. 2020;21(8):1035-1044.
View more articles from the same authors.

This study modeled the impact of different scenarios of COVID-19 lockdown-accumulated backlog in cancer referrals on cancer survival. Results suggest that, for many cancer patients, treatment delays of 2-6 months will lead to a substantial proportion of patients with early-stage tumors progressing from having curable to incurable disease. Results also indicate that even small delays (e.g., 2 months) can lead to substantial survival decrements among younger patients; among adults 70 years of age and older, balancing risk of death between cancer and COVID-19 is important.  

Save
Print
Cite
Citation

Sud A, Torr B, Jones ME, et al. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study. Lancet Oncol. 2020 Jul 20. doi: 10.1016/S1470-2045(20)30392-2.

Related Resources From the Same Author(s)
Related Resources